Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 114.70B | 113.47B | 103.72B | 97.38B | 94.45B | 118.44B |
Gross Profit | 29.29B | 29.11B | 24.48B | 21.96B | 24.00B | 50.26B |
EBITDA | 12.42B | 13.11B | 9.26B | 6.45B | 9.24B | 8.98B |
Net Income | 5.06B | 5.57B | 3.07B | 1.10B | 3.37B | 3.17B |
Balance Sheet | ||||||
Total Assets | 93.70B | 95.84B | 94.23B | 87.63B | 83.26B | 78.87B |
Cash, Cash Equivalents and Short-Term Investments | 15.41B | 17.39B | 19.59B | 16.18B | 16.79B | 14.79B |
Total Debt | 3.09B | 3.69B | 5.34B | 5.75B | 1.07B | 1.36B |
Total Liabilities | 31.52B | 34.34B | 37.80B | 34.09B | 30.48B | 28.31B |
Stockholders Equity | 62.17B | 61.49B | 56.43B | 53.54B | 52.79B | 50.56B |
Cash Flow | ||||||
Free Cash Flow | -2.18B | -294.00M | 4.46B | -3.60B | 3.18B | 2.29B |
Operating Cash Flow | 4.37B | 6.53B | 9.81B | 2.12B | 8.09B | 8.05B |
Investing Cash Flow | -6.46B | -6.47B | -5.29B | -6.74B | -5.12B | -5.63B |
Financing Cash Flow | -2.36B | -2.23B | -1.18B | 3.97B | -1.08B | -932.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥90.82B | 25.07 | 3.58% | 8.76% | 11.82% | ||
74 Outperform | ¥35.32B | 11.09 | 0.81% | 15.24% | 43.88% | ||
73 Outperform | ¥33.33B | 15.01 | 1.22% | 6.19% | 7.92% | ||
65 Neutral | ¥65.18B | 39.27 | 1.18% | 5.37% | -2.18% | ||
64 Neutral | ¥32.62B | 26.48 | 1.32% | 0.62% | -32.02% | ||
63 Neutral | ¥60.57B | 12.02 | 1.07% | 8.26% | 24.25% | ||
63 Neutral | $20.42B | 14.38 | -2.77% | 3.17% | 2.07% | -6.17% |